Target Price | €6.56 |
Price | €2.38 |
Potential |
175.74%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target BRAIN Biotech 2026 .
The average BRAIN Biotech target price is €6.56.
This is
175.74%
register free of charge
€10.00
320.17%
register free of charge
€4.80
101.68%
register free of charge
|
|
A rating was issued by 4 analysts: 3 Analysts recommend BRAIN Biotech to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BRAIN Biotech stock has an average upside potential 2026 of
175.74%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 54.63 | 60.82 |
1.28% | 11.33% | |
EBITDA Margin | -9.43% | 5.24% |
153.25% | 155.58% | |
Net Margin | -20.40% | -9.09% |
35.95% | 55.44% |
4 Analysts have issued a sales forecast BRAIN Biotech 2025 . The average BRAIN Biotech sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an BRAIN Biotech EBITDA forecast 2025. The average BRAIN Biotech EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 BRAIN Biotech Analysts have issued a net profit forecast 2025. The average BRAIN Biotech net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -0.51 | -0.25 |
34.21% | 50.98% | |
P/E | negative | |
EV/Sales | 0.91 |
3 Analysts have issued a BRAIN Biotech forecast for earnings per share. The average BRAIN Biotech EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Nov 10 2024 |
EQUI.TS |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
EQUI.TS |
Locked
➜
Locked
|
Locked | Sep 12 2024 |
Analyst Rating | Date |
---|---|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Nov 12 2024 |
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Nov 10 2024 |
Locked
EQUI.TS:
Locked
➜
Locked
|
Nov 04 2024 |
Locked
EQUI.TS:
Locked
➜
Locked
|
Sep 12 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.